Specify a stock or a cryptocurrency in the search bar to get a summary
NFL Biosciences SAS
ALNFLNFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company's natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. NFL Biosciences SA was incorporated in 2006 and is based in Castelnau-le-Lez, France. Address: 199 Rue Hélène Boucher, Castelnau-le-Lez, France, 34170
Analytics
WallStreet Target Price
5.93 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ALNFL
Dividend Analytics ALNFL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALNFL
Stock Valuation ALNFL
Financials ALNFL
Results | 2019 | Dynamics |